O	0	7	Protein	Protein	NN	B-NP
O	8	14	kinase	kinase	NN	I-NP
O	15	25	activities	activity	NNS	I-NP
O	26	28	in	in	IN	B-PP
O	29	35	immune	immune	JJ	B-NP
O	36	45	complexes	complex	NNS	I-NP
O	46	48	of	of	IN	B-PP
O	49	55	simian	simian	JJ	B-NP
O	56	61	virus	virus	NN	I-NP
O	62	64	40	40	CD	I-NP
O	65	70	large	large	JJ	I-NP
O	71	72	T	T	NN	I-NP
O	72	73	-	-	HYPH	I-NP
O	73	80	antigen	antigen	NN	I-NP
O	81	84	and	and	CC	I-NP
O	85	99	transformation	transformation	NN	I-NP
O	99	100	-	-	HYPH	B-VP
O	100	110	associated	associate	VBN	B-NP
B-Cell	111	119	cellular	cellular	JJ	I-NP
O	120	123	p53	p53	NN	I-NP
O	124	131	protein	protein	NN	I-NP
O	131	132	.	.	.	O

O	134	140	Immune	Immune	JJ	B-NP
O	141	148	complex	complex	NN	I-NP
O	149	155	kinase	kinase	NN	I-NP
O	156	162	assays	assay	NNS	I-NP
O	163	165	in	in	IN	B-PP
O	166	169	the	the	DT	B-NP
O	170	176	simian	simian	JJ	I-NP
O	177	182	virus	virus	NN	I-NP
O	183	185	40	40	CD	I-NP
O	186	192	system	system	NN	I-NP
O	193	197	were	be	VBD	B-VP
O	198	207	performed	perform	VBN	I-VP
O	208	210	by	by	IN	B-PP
O	211	221	incubation	incubation	NN	B-NP
O	222	224	of	of	IN	B-PP
O	225	243	immunoprecipitates	immunoprecipitate	NNS	B-NP
O	244	254	containing	contain	VBG	B-VP
B-Cancer	255	260	tumor	tumor	NN	B-NP
O	261	269	antigens	antigen	NNS	I-NP
O	270	274	with	with	IN	B-PP
O	275	276	[	[	(	O
O	276	281	gamma	gamma	SYM	B-NP
O	281	282	-	-	HYPH	I-NP
O	282	285	32P	32P	NN	I-NP
O	285	286	]	]	)	I-NP
O	286	289	ATP	ATP	NN	I-NP
O	289	290	,	,	,	O
O	291	299	followed	follow	VBN	B-VP
O	300	302	by	by	IN	B-PP
O	303	311	analysis	analysis	NN	B-NP
O	312	314	of	of	IN	B-PP
O	315	318	any	any	DT	B-NP
O	319	334	phosphoacceptor	phosphoacceptor	NN	I-NP
O	335	343	proteins	protein	NNS	I-NP
O	343	344	.	.	.	O

O	345	350	These	These	DT	B-NP
O	351	357	assays	assay	NNS	I-NP
O	358	365	yielded	yield	VBD	B-VP
O	366	372	mainly	mainly	RB	B-ADVP
O	373	376	the	the	DT	B-NP
O	377	382	viral	viral	JJ	I-NP
O	383	388	large	large	JJ	I-NP
O	389	390	T	T	NN	I-NP
O	390	391	-	-	HYPH	I-NP
O	391	398	antigen	antigen	NN	I-NP
O	399	402	and	and	CC	O
O	402	403	,	,	,	O
O	404	406	in	in	IN	B-PP
O	407	417	particular	particular	JJ	B-ADJP
O	417	418	,	,	,	O
O	419	422	the	the	DT	B-NP
O	423	433	associated	associated	JJ	I-NP
B-Cell	434	442	cellular	cellular	JJ	I-NP
O	443	446	p53	p53	NN	I-NP
O	447	449	as	as	IN	B-PP
O	450	460	endogenous	endogenous	JJ	B-NP
O	461	471	substrates	substrate	NNS	I-NP
O	471	472	.	.	.	O

O	473	476	The	The	DT	B-NP
O	477	483	nature	nature	NN	I-NP
O	484	486	of	of	IN	B-PP
O	487	492	these	these	DT	B-NP
O	493	503	substrates	substrate	NNS	I-NP
O	504	507	was	be	VBD	B-VP
O	508	517	confirmed	confirm	VBN	I-VP
O	518	520	by	by	IN	B-PP
O	521	532	proteolysis	proteolysis	NN	B-NP
O	533	543	techniques	technique	NNS	I-NP
O	543	544	.	.	.	O

O	545	550	Under	Under	IN	B-PP
O	551	559	specific	specific	JJ	B-NP
O	560	570	conditions	condition	NNS	I-NP
O	570	571	,	,	,	O
O	572	578	casein	casein	NN	B-NP
O	579	584	could	could	MD	B-VP
O	585	587	be	be	VB	I-VP
O	588	592	used	use	VBN	I-VP
O	593	595	as	as	IN	B-PP
O	596	598	an	an	DT	B-NP
O	599	608	exogenous	exogenous	JJ	I-NP
O	609	618	substrate	substrate	NN	I-NP
O	619	621	as	as	RB	B-ADVP
O	622	626	well	well	RB	I-ADVP
O	626	627	.	.	.	O

O	628	631	The	The	DT	B-NP
O	632	638	kinase	kinase	NN	I-NP
O	639	648	reactions	reaction	NNS	I-NP
O	649	655	showed	show	VBD	B-VP
O	656	666	preference	preference	NN	B-NP
O	667	670	for	for	IN	B-PP
O	671	674	ATP	ATP	NN	B-NP
O	675	678	and	and	CC	I-NP
O	679	684	MgCl2	MgCl2	NN	I-NP
O	685	692	instead	instead	RB	B-CONJP
O	693	695	of	of	IN	I-CONJP
O	696	699	GTP	GTP	NN	B-NP
O	700	702	or	or	CC	I-NP
O	703	708	MnCl2	MnCl2	NN	I-NP
O	708	709	.	.	.	O

O	710	714	Both	Both	CC	O
O	715	728	phosphoserine	phosphoserine	NN	B-NP
O	729	732	and	and	CC	I-NP
O	733	749	phosphothreonine	phosphothreonine	NN	I-NP
O	749	750	,	,	,	O
O	751	754	but	but	CC	O
O	755	757	in	in	IN	B-PP
O	758	760	no	no	DT	B-NP
O	761	765	case	case	NN	I-NP
O	766	781	phosphotyrosine	phosphotyrosine	NN	I-NP
O	781	782	,	,	,	O
O	783	787	were	be	VBD	B-VP
O	788	796	detected	detect	VBN	I-VP
O	797	802	after	after	IN	B-PP
O	803	805	an	an	DT	B-NP
O	806	812	immune	immune	JJ	I-NP
O	813	820	complex	complex	NN	I-NP
O	821	827	kinase	kinase	NN	I-NP
O	828	836	reaction	reaction	NN	I-NP
O	836	837	.	.	.	O

O	838	848	Apparently	Apparently	RB	B-ADVP
O	848	849	,	,	,	O
O	850	857	several	several	JJ	B-NP
O	858	860	in	in	FW	I-NP
O	861	865	vivo	vivo	FW	I-NP
O	866	881	phosphorylation	phosphorylation	NN	I-NP
O	882	887	sites	site	NNS	I-NP
O	888	892	were	be	VBD	B-VP
O	893	903	recognized	recognize	VBN	I-VP
O	904	906	in	in	FW	B-ADVP
O	907	912	vitro	vitro	FW	I-ADVP
O	913	915	in	in	IN	B-PP
O	916	920	both	both	CC	B-NP
O	921	926	large	large	JJ	I-NP
O	927	928	T	T	NN	I-NP
O	928	929	-	-	HYPH	I-NP
O	929	936	antigen	antigen	NN	I-NP
O	937	940	and	and	CC	I-NP
O	941	944	p53	p53	NN	I-NP
O	944	945	,	,	,	O
O	946	949	but	but	CC	O
O	950	953	the	the	DT	B-NP
O	954	962	presence	presence	NN	I-NP
O	963	965	of	of	IN	B-PP
O	966	970	some	some	DT	B-NP
O	971	982	artifactual	artifactual	JJ	I-NP
O	983	988	sites	site	NNS	I-NP
O	989	994	could	could	MD	B-VP
O	995	998	not	not	RB	I-VP
O	999	1001	be	be	VB	I-VP
O	1002	1012	completely	completely	RB	I-VP
O	1013	1021	excluded	exclude	VBN	I-VP
O	1021	1022	.	.	.	O

O	1023	1031	Although	Although	IN	B-SBAR
O	1032	1045	contaminating	contaminate	VBG	B-NP
O	1046	1053	kinases	kinase	NNS	I-NP
O	1054	1058	were	be	VBD	B-VP
O	1059	1069	detectable	detectable	JJ	B-ADJP
O	1070	1072	in	in	IN	B-PP
O	1073	1076	the	the	DT	B-NP
O	1077	1083	immune	immune	JJ	I-NP
O	1084	1093	complexes	complex	NNS	I-NP
O	1093	1094	,	,	,	O
O	1095	1097	at	at	IN	B-ADVP
O	1098	1103	least	least	JJS	I-ADVP
O	1104	1107	the	the	DT	B-NP
O	1108	1111	p53	p53	NN	I-NP
O	1112	1121	molecules	molecule	NNS	I-NP
O	1122	1126	were	be	VBD	B-VP
O	1127	1141	phosphorylated	phosphorylate	VBN	I-VP
O	1142	1144	in	in	FW	B-ADVP
O	1145	1150	vitro	vitro	FW	I-ADVP
O	1151	1153	in	in	IN	B-PP
O	1154	1155	a	a	DT	B-NP
O	1156	1160	more	more	RBR	I-NP
O	1161	1169	specific	specific	JJ	I-NP
O	1170	1173	way	way	NN	I-NP
O	1173	1174	.	.	.	O

O	1175	1179	This	This	DT	B-NP
O	1180	1188	followed	follow	VBN	B-VP
O	1189	1193	from	from	IN	B-PP
O	1194	1201	several	several	JJ	B-NP
O	1202	1217	characteristics	characteristic	NNS	I-NP
O	1218	1220	of	of	IN	B-PP
O	1221	1224	the	the	DT	B-NP
O	1225	1231	immune	immune	JJ	I-NP
O	1232	1239	complex	complex	NN	I-NP
O	1240	1246	kinase	kinase	NN	I-NP
O	1247	1256	reactions	reaction	NNS	I-NP
O	1257	1260	and	and	CC	O
O	1261	1271	especially	especially	RB	B-ADVP
O	1272	1276	from	from	IN	B-PP
O	1277	1280	the	the	DT	B-NP
O	1281	1287	strong	strong	JJ	I-NP
O	1288	1298	inhibition	inhibition	NN	I-NP
O	1299	1301	of	of	IN	B-PP
O	1302	1305	p53	p53	NN	B-NP
O	1306	1321	phosphorylation	phosphorylation	NN	I-NP
O	1322	1324	by	by	IN	B-PP
O	1325	1328	two	two	CD	B-NP
O	1329	1333	anti	anti	AFX	I-NP
O	1333	1334	-	-	HYPH	I-NP
O	1334	1339	large	large	JJ	I-NP
O	1339	1340	-	-	HYPH	I-NP
O	1340	1341	T	T	NN	I-NP
O	1342	1352	monoclonal	monoclonal	JJ	I-NP
O	1353	1363	antibodies	antibody	NNS	I-NP
O	1363	1364	.	.	.	O

O	1365	1367	It	It	PRP	B-NP
O	1368	1371	was	be	VBD	B-VP
O	1372	1377	shown	show	VBN	I-VP
O	1378	1382	that	that	IN	B-SBAR
O	1383	1388	large	large	JJ	B-NP
O	1389	1390	T	T	NN	I-NP
O	1390	1391	-	-	HYPH	O
O	1391	1398	antigen	antigen	NN	B-NP
O	1399	1405	showed	show	VBD	B-VP
O	1406	1416	associated	associate	VBN	I-VP
O	1417	1423	kinase	kinase	NN	B-NP
O	1424	1432	activity	activity	NN	I-NP
O	1432	1433	,	,	,	O
O	1434	1442	although	although	IN	B-SBAR
O	1443	1447	none	none	NN	B-NP
O	1448	1450	of	of	IN	B-PP
O	1451	1454	our	our	PRP$	B-NP
O	1455	1462	results	result	NNS	I-NP
O	1463	1468	could	could	MD	B-VP
O	1469	1482	unambiguously	unambiguously	RB	I-VP
O	1483	1494	demonstrate	demonstrate	VB	I-VP
O	1495	1497	an	an	DT	B-NP
O	1498	1507	intrinsic	intrinsic	JJ	I-NP
O	1508	1514	kinase	kinase	NN	I-NP
O	1515	1523	activity	activity	NN	I-NP
O	1524	1526	of	of	IN	B-PP
O	1527	1531	this	this	DT	B-NP
O	1532	1539	protein	protein	NN	I-NP
O	1539	1540	.	.	.	O

O	1541	1548	Finally	Finally	RB	B-ADVP
O	1548	1549	,	,	,	O
O	1550	1554	anti	anti	AFX	B-NP
O	1554	1555	-	-	HYPH	I-NP
O	1555	1558	p53	p53	NN	I-NP
O	1559	1569	monoclonal	monoclonal	JJ	I-NP
O	1570	1580	antibodies	antibody	NNS	I-NP
O	1581	1585	only	only	RB	B-VP
O	1586	1594	slightly	slightly	RB	I-VP
O	1595	1603	affected	affect	VBN	I-VP
O	1604	1606	in	in	FW	B-NP
O	1607	1612	vitro	vitro	FW	I-NP
O	1613	1628	phosphorylation	phosphorylation	NN	I-NP
O	1629	1638	reactions	reaction	NNS	I-NP
O	1638	1639	,	,	,	O
O	1640	1647	whereas	whereas	IN	O
O	1648	1649	a	a	DT	B-NP
O	1650	1653	p53	p53	NN	I-NP
O	1654	1662	molecule	molecule	NN	I-NP
O	1663	1667	from	from	IN	B-PP
O	1668	1669	a	a	DT	B-NP
O	1670	1676	simian	simian	JJ	I-NP
O	1677	1682	virus	virus	NN	I-NP
O	1683	1685	40	40	CD	I-NP
O	1685	1686	-	-	HYPH	B-ADJP
O	1686	1690	free	free	JJ	I-ADJP
O	1690	1691	,	,	,	O
O	1692	1702	chemically	chemically	RB	B-NP
O	1703	1714	transformed	transform	VBN	I-NP
O	1715	1720	human	human	JJ	I-NP
B-Cell	1721	1725	cell	cell	NN	I-NP
I-Cell	1726	1730	line	line	NN	I-NP
O	1731	1734	was	be	VBD	B-VP
O	1735	1738	not	not	RB	I-VP
O	1739	1753	phosphorylated	phosphorylate	VBN	I-VP
O	1754	1756	in	in	FW	B-ADVP
O	1757	1762	vitro	vitro	FW	I-ADVP
O	1763	1768	under	under	IN	B-PP
O	1769	1772	any	any	DT	B-NP
O	1773	1782	condition	condition	NN	I-NP
O	1783	1789	tested	test	VBN	B-VP
O	1789	1790	.	.	.	O

O	1791	1795	Thus	Thus	RB	B-ADVP
O	1795	1796	,	,	,	O
O	1797	1799	it	it	PRP	B-NP
O	1800	1802	is	be	VBZ	B-VP
O	1803	1809	highly	highly	RB	B-ADJP
O	1810	1818	unlikely	unlikely	JJ	I-ADJP
O	1819	1823	that	that	IN	B-SBAR
O	1824	1827	the	the	DT	B-NP
O	1828	1831	p53	p53	NN	I-NP
O	1832	1840	molecule	molecule	NN	I-NP
O	1841	1844	per	per	FW	B-ADVP
O	1845	1847	se	se	FW	I-ADVP
O	1848	1855	carries	carry	VBZ	B-VP
O	1856	1865	intrinsic	intrinsic	JJ	B-NP
O	1866	1868	or	or	CC	I-NP
O	1869	1873	even	even	RB	I-NP
O	1874	1884	associated	associate	VBN	I-NP
O	1885	1891	kinase	kinase	NN	I-NP
O	1892	1902	activities	activity	NNS	I-NP
O	1902	1903	.	.	.	O

